Click it and Unblock the Notifications
Just In
Don't Miss
-
Bigg Boss OTT 3: Renowned Journalist Deepak Chaurasia To Participate In Salman’s Show? Here’s What We Know -
IPL 2024: Impact Player Rule to be Abolished from Next Year? What is BCCI Saying? -
SEBI Investigates Adani Offshore Funds For Shareholding Disclosure Violations -
Sony’s Critically Acclaimed Helldivers 2 Rumored to Release on Xbox, Claims Industry Insider -
Log9 Unveils Amphion & Nexmile – Revolutionizing EV Asset Management -
Students of the Canadian International School in Bangalore Raise Nearly 60 Lakh Rupees for Bangalore NGOs -
Arushi Sharma-Vaibhav Vishant Wedding, Love Aaj Kal 2 Actor Looks Resplendent In A Pastel Ethnic Outfit, Pics! -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
India's first homegrown mRNA vaccine to be tested amid Omicron spike
New Delhi, Jan 17: The country's first messenger mRNA vaccine is expected to begin trials on humans in February. The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data. Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) is expected to review the data soon, the official sources said.
Gennova Biopharmaceuticals has also developed the mRNA vaccine for the Omicron variant that will be tested on humans for efficacy and immunogenicity soon, the official sources said.
mRNA vaccines belong to the category of nucleic acid vaccines, which use genetic material from disease-causing virus or pathogen to trigger an immune response against it within the body.
